The reality of our competitions mc is wildly different to some of these reports.
I think its the trial failure possibility that scalps their forecasts down to the knees. Call me naive but im not factoring in failures.
Was Wilsons the only one bold enough to project dollars in the sp if all goes well? I suspect their gigantic thorough report is better informed than these sub 50c 12month "targets".
(agree uboy, didnt see ur comment before posting this)
- Forums
- ASX - By Stock
- PER
- Ann: US FDA Feedback on Type C Meeting for ATL1102 in the US
Ann: US FDA Feedback on Type C Meeting for ATL1102 in the US, page-138
-
- There are more pages in this discussion • 54 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
MND
Monadelphous inks $200M contract with Woodside to help build Pluto LNG – but will it make Scarborough cheaper?
IGO
IGO kicks off earn-in copper drilling on-site Encounter's Yeneena play as it adopts new identity
Add PER (ASX) to my watchlist
|
|||||
Last
7.3¢ |
Change
-0.002(2.67%) |
Mkt cap ! $65.81M |
Open | High | Low | Value | Volume |
7.3¢ | 7.3¢ | 7.2¢ | $24.33K | 334.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 83420 | 7.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.3¢ | 7464 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 83420 | 0.072 |
2 | 310000 | 0.071 |
4 | 34299 | 0.070 |
2 | 28980 | 0.069 |
3 | 33055 | 0.068 |
Price($) | Vol. | No. |
---|---|---|
0.073 | 7464 | 3 |
0.075 | 37639 | 2 |
0.078 | 125476 | 3 |
0.079 | 175123 | 2 |
0.080 | 287231 | 3 |
Last trade - 12.23pm 29/07/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |